Redeye provides an update following Paxman’s Q1 2025 report. While the results fell short of our expectations, we maintain a positive view on Paxman’s outlook and argue that better and more interesting quarters are ahead of us. We have made some downward revisions based on the report; however, we now also include the CIPN segment in our forecasts, resulting in an upwardly revised fair value range.
LÄS MER
